Lancaster drug simulation company Simulations Plus has won a $1.2 million grant from the U.S. Food and Drug Administration to test the efficacy of oral cavity products.
Valley hospitals were required to spend in preparation for a surge of COVID patients that didn’t materials.
A2 Biotherapeutics in Agoura Hills closed its Series B round of financing at $71.5 million.
The L.A. County Department of Public Health announced Thursday it will revise its rules to allow nail salons and shopping malls to resume indoor operations with limited capacity.
Arcutis Biotherapeutics Inc. has made a secondary offering with 4 million shares of its stock.
West Hills Hospital on Tuesday announced Dr. Donald David as its new chief medical officer.
North Hollywood health care software company ConsejoSano has received an investment from the Bernard J. Tyson Impact Fund.
Biopharma giants Amgen Inc. and Eli Lilly on Thursday announced an antibody manufacturing collaboration for potential COVID-19 treatments.
Amgen Inc. on Tuesday announced its Golden Ticket winners — startup companies BigHat Biosciences and Trilo Therapeutics.
West Hills Hospital will close its obstetrics program effective Nov. 1, the organization announced earlier this month.
Atara Biotherapeutics has received the U.S. Food and Drug Administration’s green light to start clinical trials for its next-generation CAR T therapy.
Amgen Inc. will join the Dow Jones Industrial Index on Aug. 31, according to S&P Dow Jones Indices.
Medical device company Eyenuk Inc. announced U.S. Food and Drug Administration clearance to market its diabetic retinopathy detection software.
Cure Pharmaceutical on Tuesday announced it will acquire privately held Sera Labs in Sherman Oaks for $20 million.
Amgen Inc. beat analyst expectations during the second quarter, despite the effects of the coronavirus on the health care industry.